Cited by 1,084MicroRNA in disease regulationCancer-related molecular mechanisms researchCancer-related Molecular Pathways

The microcosmos of cancer

Open access
Lujambio, Amaia, Lowe, Scott W.·2012·Nature

Abstract

The discovery of microRNAs (miRNAs) almost two decades ago established a new paradigm of gene regulation. During the past ten years these tiny non-coding RNAs have been linked to virtually all known physiological and pathological processes, including cancer. In the same way as certain key protein-coding genes, miRNAs can be deregulated in cancer, in which they can function as a group to mark differentiation states or individually as bona fide oncogenes or tumour suppressors. Importantly, miRNA biology can be harnessed experimentally to investigate cancer phenotypes or used therapeutically as a target for drugs or as the drug itself.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature10888

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies have added numerous miRNAs to the gene constellation that p53 regulates, which contribute to its activation.

    “Recent studies have added numerous miRNAs to the gene constellation that p53 regulates48,49, which in turn contribute to its activation.”

    From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [49]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 102 · Cited by 1,084

Authors
Lujambio, A., & Lowe, S. W.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Lowe, Scott W.
Venue
Nature
Published
2012-02
Volume
482
Issue
7385
Pages
347-355
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2148929244
Cited by
1,084
References
102
Citations by year
2026: 15 · 2025: 36 · 2024: 44 · 2023: 49 · 2022: 58 · 2021: 54 · 2020: 81 · 2019: 78 · 2018: 95 · 2017: 95 · 2016: 100 · 2015: 124 · 2014: 110 · 2013: 108 · 2012: 37
FWCI
9.04
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institute on Aging (R01AG016379)
  • National Cancer Institute (P01CA013106, P30CA008748)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
microRNA, non-coding RNA, gene expression regulation, cancer, oncogenes, tumour suppressor, microRNA dysregulation, cancer therapeutics, therapeutic target
MeSH terms
Animals, Humans, Neoplasm Metastasis, Neoplasms, Oncogenes, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review